VREX: financial statements from SEC

Income statement

Metric	Sep 30, 2025	Sep 30, 2024
Revenue	845m	811m
Cost of revenue	554m	554m
Gross profit	291m	257m
Research and development	91m	87m
Selling, general and administrative	133m	138m
Operating expenses	318m	225m
Operating income	−28m	32m
Pre-tax income	−59m	5m
Income tax	11m	53m
Net income	−70m	−49m
Earnings per share	−1.70	−1.20
Earnings per share, diluted	−1.70	−1.20
Weighted average shares	41m	41m
Weighted average shares, diluted	41m	41m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	85m	—	145m	136m	205m	176m	169m	156m
Short-term investments	3m	—	10m	16m	18m	37m	32m	34m
Receivables	148m	—	157m	137m	146m	138m	158m	152m
Inventory	347m	—	299m	299m	285m	280m	265m	282m
Current assets	626m	—	642m	620m	684m	657m	650m	649m
Goodwill	198m	—	198m	199m	290m	287m	291m	289m
Total assets	1.09bn	—	1.11bn	1.07bn	1.36bn	1.33bn	1.21bn	1.25bn
Current liabilities	195m	—	187m	177m	169m	151m	196m	195m
Short-term debt	19m	—	2m	2m	1m	1m	46m	46m
Long-term debt	329m	—	366m	366m	566m	566m	397m	397m
Total liabilities	601m	—	621m	604m	794m	778m	670m	657m
Equity	474m	491m	473m	455m	558m	554m	529m	590m
Shares outstanding	42m	—	42m	42m	42m	41m	41m	41m
Shares issued	42m	—	42m	42m	42m	41m	41m	41m

Metric	Sep 30, 2025	Sep 30, 2024
Operating cash flow	42m	47m
Depreciation and amortisation	23m	21m
Share-based compensation	15m	15m
Capital expenditure	23m	27m
Investing cash flow	10m	−28m
Financing cash flow	−76m	−3m